COMPOSITIONS AND METHODS FOR PURIFICATION AND DETECTION OF HDL AND APOAI

    公开(公告)号:US20250027960A1

    公开(公告)日:2025-01-23

    申请号:US18829111

    申请日:2024-09-09

    Abstract: The present invention provides methods, kits, and compositions for purifying HDL molecules from a sample (e.g., blood sample) using HDL tagging molecules comprising an HDL lipophilic core binding peptide (e.g., portion of ApoA1) and an affinity tag. The present invention also provides methods, kits, and compositions for detecting non-fragmented ApoA1 with mass spectrometry. The present invention further provides methods, kits, and compositions for tagging HDL molecules in a sample with detectably labeled ApoA1 molecules such that the ratio of detectably labeled ApoA1 molecules to native ApoA1 proteins may be determined.

    COMPOSITIONS AND METHODS FOR PURIFICATION AND DETECTION OF HDL AND APOA1
    3.
    发明申请
    COMPOSITIONS AND METHODS FOR PURIFICATION AND DETECTION OF HDL AND APOA1 审中-公开
    用于纯化和检测HDL和APOA1的组合物和方法

    公开(公告)号:US20150331000A1

    公开(公告)日:2015-11-19

    申请号:US14713046

    申请日:2015-05-15

    CPC classification number: G01N33/92 C07K14/775 G01N1/34

    Abstract: The present invention provides methods, kits, and compositions for purifying HDL molecules from a sample (e.g., blood sample) using HDL tagging molecules comprising an HDL lipophilic core binding peptide (e.g., portion of ApoA1) and an affinity tag. The present invention also provides methods, kits, and compositions for detecting non-fragmented ApoA1 with mass spectrometry. The present invention further provides methods, kits, and compositions for tagging HDL molecules in a sample with detectably labeled ApoA1 molecules such that the ratio of detectably labeled ApoA1 molecules to native ApoA1 proteins may be determined.

    Abstract translation: 本发明提供了使用包含HDL亲脂性核心结合肽(例如,ApoA1的部分)和亲和标签的HDL标记分子从样品(例如血液样品)中纯化HDL分子的方法,试剂盒和组合物。 本发明还提供用质谱法检测非碎片化的ApoA1的方法,试剂盒和组合物。 本发明还提供用于标记具有可检测标记的ApoA1分子的样品中的HDL分子的方法,试剂盒和组合物,使得可测定可检测标记的ApoA1分子与天然ApoA1蛋白的比例。

    Compositions and methods for purification and detection of HDL and ApoA1

    公开(公告)号:US11061039B2

    公开(公告)日:2021-07-13

    申请号:US16208739

    申请日:2018-12-04

    Abstract: The present invention provides methods, kits, and compositions for purifying HDL molecules from a sample (e.g., blood sample) using HDL tagging molecules comprising an HDL lipophilic core binding peptide (e.g., portion of ApoA1) and an affinity tag. The present invention also provides methods, kits, and compositions for detecting non-fragmented ApoA1 with mass spectrometry. The present invention further provides methods, kits, and compositions for tagging HDL molecules in a sample with detectably labeled ApoA1 molecules such that the ratio of detectably labeled ApoA1 molecules to native ApoA1 proteins may be determined.

    COMPOSITIONS AND METHODS FOR PURIFICATION AND DETECTION OF HDL AND APOAI

    公开(公告)号:US20210373038A1

    公开(公告)日:2021-12-02

    申请号:US17367049

    申请日:2021-07-02

    Abstract: The present invention provides methods, kits, and compositions for purifying HDL molecules from a sample (e.g., blood sample) using HDL tagging molecules comprising an HDL lipophilic core binding peptide (e.g., portion of ApoA1) and an affinity tag. The present invention also provides methods, kits, and compositions for detecting non-fragmented ApoA1 with mass spectrometry. The present invention further provides methods, kits, and compositions for tagging HDL molecules in a sample with detectably labeled ApoA1 molecules such that the ratio of detectably labeled ApoA1 molecules to native ApoA1 proteins may be determined.

    Compositions and methods for purification and detection of HDL and ApoA1

    公开(公告)号:US10151764B2

    公开(公告)日:2018-12-11

    申请号:US14713046

    申请日:2015-05-15

    Abstract: The present invention provides methods, kits, and compositions for purifying HDL molecules from a sample (e.g., blood sample) using HDL tagging molecules comprising an HDL lipophilic core binding peptide (e.g., portion of ApoA1) and an affinity tag. The present invention also provides methods, kits, and compositions for detecting non-fragmented ApoA1 with mass spectrometry. The present invention further provides methods, kits, and compositions for tagging HDL molecules in a sample with detectably labeled ApoA1 molecules such that the ratio of detectably labeled ApoA1 molecules to native ApoA1 proteins may be determined.

Patent Agency Ranking